Copyright
©The Author(s) 2025.
World J Methodol. Dec 20, 2025; 15(4): 105478
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.105478
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.105478
Figure 1 Flowchart on study retrieval and inclusion in the meta-analysis.
GLP-1RA: Glucagon-like peptide-1 receptor agonist.
Figure 2 Forest plot demonstrating the mean difference.
A: Glycated hemoglobin; B: Body weight in the glucagon-like peptide-1 receptor agonist (GLP-1RA) group vs the non-GLP-1RA group. GLP-1RA: Glucagon-like peptide-1 receptor agonist; MD: Mean difference.
Figure 3 Forest plot demonstrating the mean difference.
A: Systolic blood pressure (BP); B: Diastolic BP; C: Total cholesterol; D: Triglyceride in the glucagon-like peptide-1 receptor agonist (GLP-1RA) group vs the non-GLP-1RA group. GLP-1RA: Glucagon-like peptide-1 receptor agonist; MD: Mean difference.
- Citation: Kamrul-Hasan ABM, Pappachan JM, Ashraf H, Nagendra L, Dutta D, Kuchay MS, Shaikh S. Safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with type 2 diabetes mellitus fasting during Ramadan: a systematic review and meta-analysis. World J Methodol 2025; 15(4): 105478
- URL: https://www.wjgnet.com/2222-0682/full/v15/i4/105478.htm
- DOI: https://dx.doi.org/10.5662/wjm.v15.i4.105478